Pegcetacoplan treatment meaningfully improves quality of life and fatigue in patients with paroxysmal nocturnal hemoglobinuria: results from two phase 3 clinical trials

Authors
Category Primary study
ConferenceBone Marrow Transplantation
Year 2022
This article has no abstract
Epistemonikos ID: fb8857aff495e0e21278b3e8f92c1eab1c27636a
First added on: Apr 30, 2026